Literature DB >> 4404326

Enzyme activities of the livers of mice infected with Salmonella typhimurium.

I S Snyder.   

Abstract

The activities of the mouse liver enzymes tryptophan oxygenase, tyrosine aminotransferase, and pyruvate kinase were measured after infection with three dose levels of Salmonella typhimurium strain SR-11. Infection occurred in all groups as evidenced by an increase in bacterial numbers and by death of the animals. The activities of the enzymes increased in all groups during the course of the infection. The results obtained during infection are compared with those obtained after endotoxin injection.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4404326      PMCID: PMC416323          DOI: 10.1128/iai.4.4.411-415.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  INSULIN: INDUCER OF PYRUVATE KINASE.

Authors:  G WEBER; N B STAMM; E A FISHER
Journal:  Science       Date:  1965-07-02       Impact factor: 47.728

2.  The role of endotoxin during typhoid fever and tularemia in man. I. Acquisition of tolerance to endotoxin.

Authors:  S E GREISMAN; R B HORNICK; F A CAROZZA; T E WOODWARD
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

Review 3.  Synchronous behavior pattern of key glycolytic enzymes: glucokinase, phosphofructokinase, and pyruvate kinase.

Authors:  G Weber; R L Singhal; N B Stamm; M A Lea; E A Fisher
Journal:  Adv Enzyme Regul       Date:  1966

4.  Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids.

Authors:  G Weber; H J Convery; M A Lea; N B Stamm
Journal:  Science       Date:  1966-12-09       Impact factor: 47.728

Review 5.  Molecular aspects of endotoxic reactions.

Authors:  A Nowotny
Journal:  Bacteriol Rev       Date:  1969-03

6.  Host enzyme induction of bacterial infection.

Authors:  M I Rapoport; G Lust; W R Beisel
Journal:  Arch Intern Med       Date:  1968-01

7.  Tryptophan metabolism during infectious illness in man.

Authors:  M I Rapoport; W R Beisel; R B Hornick
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

8.  Inhibition of inducible liver enzymes by endotoxin and actinomycin D.

Authors:  L J Berry; D S Smythe; L S Colwell
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

9.  EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISM. VII. ENZYME INDUCTION AND CORTISONE PROTECTION.

Authors:  L J BERRY; D S SMYTHE
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Effect of bacterial endotoxin on metabolism. II Protein-carbohydrate balance following cortisone. Inhibition of intestinal absorption and adrenal response to ACTH.

Authors:  L J BERRY; D S SMYTHE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  5 in total

1.  Effect of lipopolysaccharide and lipid A on mouse liver pyruvate kinase activity.

Authors:  S M Smith; I S Snyder
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

2.  Inhibition of hepatic gluconeogenesis by nitric oxide: a comparison with endotoxic shock.

Authors:  R A Horton; E D Ceppi; R G Knowles; M A Titheradge
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

3.  Comparative dynamics of salmonella infection after primary and secondary challenge of mice exposed to 10 and 23 C.

Authors:  J J Previte; J C Alden; M Egbert
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

4.  Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells.

Authors:  E D Ceppi; R G Knowles; K M Carpenter; M A Titheradge
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

5.  The effect of treatment of the rat with bacterial endotoxin on gluconeogenesis and pyruvate metabolism in subsequently isolated hepatocytes.

Authors:  C G Jones; M A Titheradge
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.